Pelagos Insurance Capital Ltd is a US-listed company in the property & casualty insurance industry. Its financial year ends in December.
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months was $2.50bn, up 3.3% on a year earlier, against a decline of 32.7% a quarter earlier. The diluted share count is down 7.7% on a year earlier, which lifts each remaining share.
Our model value for Pelagos Insurance Capital is under review, so past values are not shown until it is resolved.
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Pelagos Insurance Capital Ltd's trailing-twelve-month revenue grew 3.3% year on year, with a free-cash-flow margin of -16.4%. Where it stands out: change in growth rate of +36.0pp ranks 1 of 48 property & casualty insurance companies we cover.
Current signal Revenue growth accelerating: TTM revenue growth rose to 3.3% (+36.0pp vs the prior quarter).
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
No recent updates are available for PLGO from the sources we follow. See filings →
No model value for Pelagos Insurance Capital Ltd at the moment. Current status: valuation models disagree too widely to rate. Available reported financials are shown below.
The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.
We value Pelagos Insurance Capital Ltd as an insurer, with every model that fits that kind of business. Cost of equity 7.8%: the 10-year Treasury yield (4.9%) plus a beta of 0.63 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | ~$160 ~$110–$240 | Left out: out of range vs price (5.97x) |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | ~$110 ~$87–$130 | Included |
| Price-to-book vs return on equity (peers) The price-to-book that peers with this return on equity trade on, from a line fitted across peers. | ~$64 ~$47–$80 | Included |
| Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. | ~$32 ~$29–$56 | Included |
| Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. | ~$40 ~$35–$50 | Included |
| Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. | ~$110 ~$89–$150 | Included |
| Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. | — | Combined value withheld. Review the individual models and their assumptions. |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Pelagos Insurance Capital Ltd with property, casualty and specialty insurers in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Next results: November 11, 2026, after the close. Analysts expect revenue of $708m and EPS of $0.71 (range $0.36 to $1.09) for the quarter.
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $3.05 | +59% | $2.6bn | +6% |
| Next | $3.91 | +28% | $2.8bn | +6% |
Next year's EPS estimate has moved −3.7% in 90 days, across 9 analysts.
The consensus EPS forecast for the current fiscal year is −13.9% on 90 days ago. In the last 30 days, 2 analysts raised Pelagos Insurance Capital Ltd's forecast and 4 cut it.
Average of analysts' published estimates (third-party data).
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | $3.54 | $4.07 |
| 60 days ago | $3.01 | $4.01 |
| 30 days ago | $2.98 | $3.89 |
| 7 days ago | $2.99 | $3.89 |
| Now | $3.05 | $3.91 |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | $0.88 | $0.34 | −61.2% |
| Mar 2026 | $0.73 | $0.94 | +29.1% |
| Dec 2025 | $1.08 | $1.09 | +1.4% |
| Sept 2025 | $1.20 | $1.21 | +1.0% |
Adjusted EPS as companies report it, against the average analyst estimate.
| Calendar year | 2024 | 2025 | 2026 to date |
|---|---|---|---|
| Return | |||
| PLGO | +46% | +9% | +38% |
| Industry peers (median) | +30% | +7% | +10% |
| S&P 500 | +25% | +18% | +11% |
| Months that ended higher | |||
| PLGO | 50% | 58% | 73% |
| S&P 500 | 75% | 75% | 46% |
| Largest fall from a high during the year | |||
| PLGO | −22% | −21% | −12% |
| S&P 500 | −8% | −19% | −9% |
Worst fall since June 29, 2023: 30% from November 27, 2024 to February 25, 2025. Getting back needed a 43% gain, reached on April 9, 2026, 408 days after the low.
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Revenue (TTM) |
|---|---|
| FY21 Q4 | $1.2B |
| FY22 Q4 | $1.5B |
| FY23 Q4 | $3.6B |
| FY24 Q4 | $2.4B |
| FY25 Q4 | $2.5B |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY22 Q4 | 26.3% |
| FY23 Q4 | 138.3% |
| FY24 Q4 | -32.7% |
| FY25 Q4 | 3.3% |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | FCF margin (TTM) |
|---|---|
| FY21 Q4 | 28.3% |
| FY22 Q4 | 47.9% |
| FY23 Q4 | 13.6% |
| FY24 Q4 | 25.4% |
| FY25 Q4 | -16.4% |
| Fiscal year | 2021 Dec 2021 | 2022 Dec 2022 | 2023 Dec 2023 | 2024 Dec 2024 | 2025 Dec 2025 |
|---|---|---|---|---|---|
| Income | |||||
| Revenue | 1,195 | 1,509 | 3,596 | 2,420 | 2,501 |
| Net income | 68 | 53 | 2,133 | 113 | 226 |
| Diluted EPS | $0.34 | $0.26 | $18.65 | $0.98 | $2.11 |
| Growth (year on year) | |||||
| Revenue | — | +26.3% | +138.3% | −32.7% | +3.3% |
| Net income | — | −23.0% | +>999% | −94.7% | +99.0% |
| Diluted EPS | — | −23.5% | +>999% | −94.7% | +115.3% |
| Margins | |||||
| Net margin | 5.7% | 3.5% | 59.3% | 4.7% | 9.0% |
| Free-cash-flow margin | 28.3% | 47.9% | 13.6% | 25.4% | −16.4% |
| Cash flow | |||||
| Cash from operations | 346 | 741 | 495 | 618 | −408 |
| Capital spending | 7 | 19 | 6 | 5 | 1 |
| Free cash flow | 339 | 723 | 489 | 614 | −410 |
| Stock-based pay | 10 | 11 | 28 | 8 | 8 |
| Free cash flow after stock pay | 329 | 712 | 461 | 606 | −417 |
| Balance sheet | |||||
| Cash | 476 | 1,222 | 712 | 743 | 873 |
| Total debt | 0 | 455 | 455 | 455 | 855 |
| Net debt (negative = net cash) | −476 | −767 | −257 | −288 | −18 |
| Diluted shares | 200m | 199m | 114m | 116m | 107m |
| Returned to shareholders | |||||
| Dividends | 2 | 1 | 0 | 46 | 52 |
| Buybacks | 321 | 0 | 0 | 106 | 261 |
| Total returned | 323 | 1 | 0 | 152 | 314 |
| Last 12 months unless stated | PLGO | KNSL | RLI | STC | SKWD | UVE | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $2.5bn | $2.0bn | $1.9bn | $3.3bn | $1.7bn | $1.7bn | $1.7bn |
| Revenue growth, last 12 months | 3.3% | 8.3% | 4.6% | 22.5% | 38.3% | 5.5% | 8.0% |
| Revenue growth, 3-year average | — | 20.3% | 10.5% | 10.1% | 32.5% | 7.4% | 9.5% |
| Revenue growth, latest quarter | — | −8.6% | −6.3% | 24.5% | 53.0% | 9.6% | 4.2% |
| Net margin | 9.0% | 26.9% | 20.3% | 4.1% | 10.8% | 13.9% | 10.5% |
| Cash from operations / revenue | −16.3% | 51.0% | 27.8% | 7.3% | 23.5% | 21.9% | 18.2% |
| Free-cash-flow margin | −16.4% | 49.8% | 27.4% | 4.6% | 23.5% | 21.6% | 17.6% |
| Free-cash-flow margin, 3-year average | — | 55.4% | 29.9% | 3.7% | 28.7% | 17.6% | 16.5% |
| Stock pay / revenue | 0.3% | 1.1% | 0.4% | 0.6% | 1.0% | 3.2% | 0.6% |
| Change in share count | −7.7% | −1.8% | −0.3% | 5.4% | 4.8% | −0.4% | −0.7% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 3.3% | 8.3% | 34 of 48 |
| Change in growth rate Growth | +36.0pp | -0.7pp | 1 of 48 |
| Net margin Profitability | 9.0% | 10.8% | 29 of 48 |
| Stock pay as % of revenue Cash generation | 0.3% | 0.7% | 6 of 34 |
| Change in share count Balance sheet | -7.7% | -0.7% | 5 of 47 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Crestview Partners Iii Gp, L.P. | $237M | 9.7M | 14.6% | 0.0% |
| Cooperman Leon G | $207M | 8.5M | 12.8% | ▲ 6.6% |
| Travelers Companies, Inc. | $141M | 5.8M | 8.7% | ▼ 12.4% |
| Pine Brook Road Advisors, L.P. | $140M | 5.8M | 8.7% | ▼ 20.0% |
| LSV Asset Management | $116M | 4.8M | 7.1% | ▼ 2.4% |
| Crestview Partners Iv Gp, L.P. | $110M | 4.5M | 6.8% | 0.0% |
| Dimensional Fund Advisors LP | $78.7M | 3.2M | 4.9% | ▲ 14.5% |
| Blackrock, Inc. | $75M | 3.1M | 4.6% | ▼ 6.7% |
| American Century Companies Inc | $36.5M | 1.5M | 2.3% | ▲ 14.2% |
| Royce & Associates LP | $26.3M | 1.1M | 1.6% | ▼ 9.2% |
| Nfc Investments, LLC | $22.4M | 918K | 1.4% | ▲ 0.2% |
| State Street Corp | $20.1M | 825K | 1.2% | ▼ 5.8% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Pelagos Insurance Capital Ltd's complete shareholder register. Values are as reported by the filers .
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
